LumiraDx Ltd

Pharmaceutical company · London, England, United Kingdom

LumiraDx Ltd is a pharmaceutical company headquartered in London, England, United Kingdom. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $164 million sold in a notice filed in 2020.

Profile compiled from public records. Is this your company? Request a correction or update

LumiraDx at a glance

Typepharmaceutical company

HeadquartersLondon, England, United Kingdom

Earliest incorporation on record2016

SEC industryPharmaceutical Preparations

SEC CIK1685428

What does LumiraDx do?

Private fundraising reported to the SEC

11 Form D notices; the most recent reported $164 million sold (2020).

Frequently asked questions about LumiraDx

Where is LumiraDx headquartered?

LumiraDx Ltd is headquartered in London, England, United Kingdom.

What does LumiraDx do?

LumiraDx Ltd is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

When was LumiraDx founded?

The earliest incorporation on record for LumiraDx Ltd is in 2016, according to public company registers.

Similar companies

Silence Therapeutics plcLondon, England, United Kingdom
Kiniksa Pharmaceuticals International, plcLondon, England, United Kingdom
Verona Pharma plcLondon, England, United Kingdom
Mereo BioPharma Group plcLondon, England, United Kingdom
Tiziana Life Sciences LtdLondon, England, United Kingdom
Eyebiotech LtdLondon, England, United Kingdom
Realm Therapeutics plcLondon, England, United Kingdom
Autolus LimitedLondon, England, United Kingdom

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences